The Latest Cardiac and Vascular News
NEW HOPE, Pa., Dec. 04, 2018 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing advanced therapeutic solutions to address major unmet medical needs, announced today that it has appointed Evan Ballantyne as its Chief Financial Officer (CFO). Mr. Ballantyne is an experienced financial and […]
SAN FRANCISCO–(BUSINESS WIRE)–Revive Solutions, Inc. (“Revive” or the “Company”), a leading developer of a next generation Automated External Defibrillator (“AED”) addressing the global public health issue of Sudden Cardiac Arrest (“SCA”), has announced the completion of its $3.4M Seed Financing Round, which was led by new investor, Greenbox Venture Partners, […]
NASHUA, N.H., Dec. 3, 2018 /PRNewswire/ — Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Seal for LAA occlusion, has secured $9 million in Series B funding. Conformal is developing proprietary seal technology for the prevention of stroke in patients with atrial fibrillation (AFib). Over five million people in the United States have AFib, […]
VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) — Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces the release of the Company’s Condensed Consolidated Interim Financial Statements and the Management’s Discussion and Analysis for the three and nine month period ended September 30, 2018 and 2017 which are […]
HOUSTON, Nov. 29, 2018 /PRNewswire/ — Millar, Inc., medical device manufacturer and OEM innovation partner, announced today that the company will end its distribution agreement with CD Leycom, manufacturer of the clinical Inca® Pressure-Volume (PV) Loop System, on December 31, 2018. Millar has been the exclusive distributor within North America for CD Leycom since November 2013. The CD Leycom Inca […]
MILFORD, Massachusetts – ( BUSINESS WIRE ) – Reprieve Cardiovascular ™, a pioneering medical device company focused on improving the treatment of patients with acute decompensated heart failure (ADHF), will soon be at various well-known sites Conferences for Heart Failure represented. Reprieve-guided diuretic therapy will be the subject of the two presentations […]
BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 28, 2018 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin’s president and chief executive officer, is scheduled to participate in a fireside chat regarding […]
Santa Monica, CA, Nov. 28, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company formed a Clinical Advisory Board to complement existing scientific […]
ANCHORAGE, Alaska, Nov. 27, 2018 /PRNewswire/ — Alaska Heart & Vascular Institute (AHVI) is pleased to announce the addition of Carson S. Webb, M.D. to the Mat-Su clinic in Palmer, AK. Dr. Webb graduated with a degree in medicine from the University of South Alabama in 2000. He specializes in percutaneous coronary, peripheral arterial, and peripheral venous interventions. […]
BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 26, 2018 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced a registered underwritten public offering of its American Depositary Shares (“ADSs”). All of the shares in the proposed offering are to be sold by Amarin. The offering is subject to market conditions, […]
